HK Stock Market Move | TRANSTHERA-B (02617) fell more than 5%, intending to issue new shares at a discount of around 18%, raising net funds of HK$2.82 billion.

TRANSTHERA-B (02617) fell more than 5%, as of the time of publication, it has fallen by 5.54%, to 65.7 Hong Kong dollars, with a turnover of 25.98 million Hong Kong dollars. In terms of news, Yaoje Health announced that it plans to issue 5.085 million H shares, equivalent to approximately 1.65% of the expanded H shares and approximately 1.26% of the total number of shares issued. The issue price per share is 57.03 Hong Kong dollars, a discount of 18% from the closing price of 69.55 Hong Kong dollars on April 14. The total amount raised is 290 million Hong Kong dollars, with a net amount of 282 million Hong Kong dollars. Approximately 57% of the net amount raised will be used for research and development, including the clinical development of the core product Tinengotinib in late-stage breast cancer, hepatocellular carcinoma, castration-resistant prostate cancer, and the clinical development of TT-00973; Approximately 33% will be used for the production and commercialization of the core product Tinengotinib in China, including the establishment of a commercial team and related marketing activities; and about 10% will be used for working capital and general corporate purposes.